MicroRNA 4447 (MIR4447)

MicroRNA 4447 (MIR4447, hsa-mir-4447) is predicted to be a member of the microRNA family in humans, which represents short non-coding RNAs that regulate gene expression at the post-transcriptional level by binding complementary sequences on target messenger RNAs, leading to repression or degradation[3][2]. MicroRNAs play crucial roles in controlling development, cellular homeostasis, robustness of gene expression, and disease pathology, but MIR4447 itself is uncharacterized in terms of sequence, targets, specific biological function, clinical relevance, or therapeutic targeting. As of now, MIR4447 cannot be considered a validated therapeutic target, clinical biomarker, or disease-associated molecule due to the absence of peer-reviewed evidence[2][3][1][4].

Other names

hsa-mir-4447MIR4447